Catalyst Wire Dossier Catalyst Wire Dossier

MM-121

seribantumab · Merrimack Pharmaceuticals
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for MM-121, covering 2016-05-12 to 2021-10-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC [Phase 2]

See pricing